Faron Pharmaceuticals - Innovative medical solutions (Part 2)

3000€/month is, in my opinion, quite acceptable for a listed company. However, those on the company’s payroll should NOT be paid for their board work. They are, after all, doing board work during their working hours, for which they receive salary.

Is it good governance for the CEO to sit on the board? Perhaps in SMEs, but not desirable in listed companies.

Do shareholders want Jalkanen to lead himself, and can the board critically evaluate him if Jalkanen is there?

4 Likes